A clinical trial design in which neither the subject nor the investigator knows whether the subject is receiving the experimental drug or a placebo. To achieve double-blinding, random numbers are assigned to the subject and the test preparations and the classification into the respective group is performed. In addition, the packaging and dosage forms are kept identical.